TABLE 1.
Cell line | Tissue type | % CD46 expression | % eGFP+ cells
|
Median fluorescence
|
||
---|---|---|---|---|---|---|
Ad11 | Ad35 | Ad11 | Ad35 | |||
K562 | Erythroid | 100 | 78.6 | 75.3 | 23.9 | 22.2 |
SK-N-MC | Neuronal | 0 | 43.2 | 51.4 | 23.3 | 26.7 |
MCF-7 | Breast | 98 | 99.7 | 98.0 | 4,043.0 | 5,953.0 |
HS766T | Pancreas | 100 | 99.8 | 99.8 | 9,589.0 | 9,493.0 |
Cells were seeded at 105 cells per ml in 6-well plates and subsequently exposed to 1,000 vp (per cell) of either Ad11 or Ad35 vector carrying eGFP. Forty-eight hours later, cells were harvested, washed, and subjected to FACS analysis. Background fluorescence of each cell population was set at 1% with nontransduced cells. Both the percentage of GFP-positive (GFP+) cells as well as the median fluorescence per cell are shown. Cell membrane expression of the BC-1 isoform of CD46 was determined by using antibody CD46 (WS IV) clone 122.2 at a 1-in-50 dilution (stock concentration, 2.57 mg/ml). As a negative control, secondary antibody fluorescein isothiocyanate- labeled goat anti-mouse immunoglobulin alone was tested at the same concentration.